Table I.

Clinical and Laboratory Features of SLE Patients at Screening.

	Poor Pregnancy Outcome N (%)	Uncomplicated Pregnancy N (%)
Clinical *
Cutaneous	18/28 (64%)	15/27 (59%)
Arthritis	20/28 (71%)	19/27 (70%)
Serositis	5/28 (18%)	7/27 (26%)
Hematologic	14/28 (50%)	14/27 (52%)
Renal	15/28 (54%)	10/27 (37%)
Laboratory
Anti-DNA	16/28 (57%)	9/26 (35%)
Anti-Ro	9/25 (36%)	16/25 (64%) †
Anti-La	2/25 (8%)	6/25 (24%)
Low C3	16/28 (57%)	7/27 (26%) §
Medications
Hydroxychloroquine use	17/28 (61%)	16/27 (59%)
Steroids use	16/28 (57%)	11/27 (41%)
Age (Mean ± SD)	31.6 ± 3.9	31.4 ± 4.5
SLEPDAI (Mean ± SD)	4.6 ± 3.5	2.2 ± 2.7 ‡

^*defined according to ACR criteria for SLE

^†p = 0.05

^§p = 0.02

^‡p < 0.01